Perioperative blood transfusions: indications and options

Area of Science:

• Transfusion Medicine
• Hematology
• Surgical Patient Care

Background:

• Transfusion-induced HIV highlighted the need to reevaluate allogeneic blood transfusion practices.
• Traditional transfusion triggers based on hemoglobin and hematocrit levels are being reconsidered.
• Patient tissue oxygen demand is emerging as a critical factor in transfusion decisions.

Purpose of the Study:

• To reevaluate the indications for allogeneic blood transfusions.
• To explore alternatives to allogeneic blood transfusion.
• To assess strategies for optimizing transfusion support in surgical patients.

Main Methods:

• Shift in transfusion trigger from fixed hemoglobin/hematocrit (10/30) to physiologically determined oxygen demand.
• Evaluation of autologous blood options to minimize allogeneic blood use.
• Review of pharmacologic interventions (e.g., erythropoietin) and surgical blood loss reduction techniques.
• Assessment of the role of blood substitutes in transfusion support.

Main Results:

• Physiologic measurements are crucial for determining the critical hemoglobin level for tissue oxygenation.
• Autologous blood strategies can significantly reduce reliance on allogeneic transfusions.
• Pharmacologic agents and surgical techniques can optimize hemoglobin levels and minimize blood loss.

Conclusions:

• Modern transfusion practices prioritize patient-specific physiological needs over arbitrary thresholds.
• A combination of autologous options, pharmacologic therapies, and potentially blood substitutes offers comprehensive transfusion alternatives.
• These strategies enhance patient safety and optimize outcomes in surgical settings.